Genstar Capital has turned to UBS and Credit Suisse First Boston to fund its acquisition of Harlan Sprague Dawley. The banks are expected to launch syndication of $190 million in loans tomorrow. The deal consists of a five-year, $15 million revolver; a five-year, $15 million euro-equivalent revolver and a six-year, $160 million term loan. Pricing could not be determined by press time.
Based in Indianapolis, Ind., Harlan provides laboratory animals and services to the scientific community. It produces over 250 stocks and strains of laboratory animals. A Genstar spokeswoman declined comment.